Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The crystal structures of the human androgen receptor (hAR) and human progesterone receptor ligand-binding domains in complex with the same ligand metribolone (R1881) have been determined. Both three-dimensional structures show the typical nuclear receptor fold. The change of two residues in the ligand-binding pocket between the human progesterone receptor and hAR is most likely the source for the specificity of R1881 to the hAR. The structural implications of the 14 known mutations in the ligand-binding pocket of the hAR ligand-binding domains associated with either prostate cancer or the partial or complete androgen receptor insensitivity syndrome were analyzed. The effects of most of these mutants could be explained on the basis of the crystal structure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The LBD and DBD X-ray crystal structures of AR have been solved separately (Matias et al., 2000; Sack et al., 2001; Shaffer et al., 2004).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Matias et al., 2000
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,578
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,953
Research works printed but not linked: 8
- Otwinowski, 1997, 276, 307
- Lamzin, 1997, 277, 269
- Kleywegt, 1995, Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography, 31, 45
- Bellis, 1992, Mol. Endocrinol., 6, 1909
- Pinsky, 1992, Clin. Invest. Med., 15, 456
- Lumbroso, 1996, J. Clin. Endocrinol. & Metab., 81, 1984
- Jakubicza, 1992, Hum. Genet., 90, 311
- Nakao, 1992, J. Clin. Endocrinol. & Metab., 74, 1152
Cited by
Items 201–300 of 696
Kumar, N., Fagart, J., Lière, P., Mitchell, S. J., Knibb, A. R., Petit-Topin, I., Rame, M., El‐Etr, M., Schumacher, M., Lambert, J. J., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1426 · Cited by 55
The evolution of progesterone receptor ligands
Madauss, K. P., Stewart, E. L., & Williams, S. P. (2007) · Medicinal Research Reviews · doi:10.1002/med.20083 · Cited by 53
Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors
Petit-Topin, I., Fay, M., Resche-Rigon, M., Ulmann, A., Gainer, E., Rafestin-Oblin, M. E., & Fagart, J. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.08.008 · Cited by 53
Norris, J. D., Joseph, J. D., Sherk, A. B., Juzumiene, D., Turnbull, P. S., Rafferty, S. W., Cui, H., Anderson, E., Fan, D., Dye, D. A., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.016 · Cited by 52
Androgen receptor as a therapeutic target
Gao, W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.002 · Cited by 53
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function
Rouhimoghadam, M., Lu, A. S., Salem, A. K., & Filardo, E. J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.591217 · Cited by 52
Domain Interactions between Coregulator ARA70 and the Androgen Receptor (AR)
Zhou, Z.-X. (2002) · Molecular Endocrinology · doi:10.1210/me.16.2.287 · Cited by 50
Targeting the Androgen Receptor with Steroid Conjugates
Levine, P. M., Garabedian, M. J., & Kirshenbaum, K. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500101h · Cited by 51
Sartorato, P., Cluzeaud, F., Fagart, J., Viengchareun, S., Lombès, M., & Zennaro, M. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0408 · Cited by 48
Nuclear receptors and disease: androgen receptor
Gottlieb, B., Beitel, L. K., Wu, J., Elhaji, Y. A., & Trifiro, M. A. (2004) · Essays in Biochemistry · doi:10.1042/bse0400121 · Cited by 48
Goto, T., Ohta, K., Suzuki, T., Ohta, S., & Endo, Y. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.061 · Cited by 48
Hess-Wilson, J. K., Webb, S. L., Daly, H. K., Leung, Y., Boldison, J., Comstock, C. E. S., Sartor, M. A., Ho, S., & Knudsen, K. E. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10283 · Cited by 49
Physiology of Testicular Steroidogenesis
Stocco, D. M., & McPhaul, M. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50025-7 · Cited by 51
Petit-Topin, I., Turque, N., Fagart, J., Fay, M., Ulmann, A., Gainer, E., & Rafestin-Oblin, M. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054312 · Cited by 47
Söderholm, A. A., Lehtovuori, P. T., & Nyrönen, T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0495879 · Cited by 47
Androgens in Health and Disease
Bagatell, C., & Bremner, W. J. (2003) · Humana Press eBooks · doi:10.1385/1592593887 · Cited by 46
Structure-based Virtual Screening and Identification of a Novel Androgen Receptor Antagonist
Song, C.-H., Yang, S., Park, E., Cho, S. H., Gong, E., Khadka, D. B., Cho, W., & Lee, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379107 · Cited by 46
Androgen Physiology: Receptor and Metabolic Disorders
McEwan, I. J., & Brinkmann, A. O. (2016) · Cited by 46
Rafestin-Oblin, M. E., Fagart, J., Souque, A., Seguin, C., Bens, M., & Vandewalle, A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1306 · Cited by 46
Androgen signalling in the ovaries and endometrium
Lissaman, A. C., Girling, J. E., Cree, L. M., Campbell, R. E., & Ponnampalam, A. P. (2023) · Molecular Human Reproduction · doi:10.1093/molehr/gaad017 · Cited by 45
Steroid Receptors in the Ovary and Uterus
Couse, J. F., Hewitt, S. C., & Korach, K. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50020-8 · Cited by 46
Molecular Basis of Steroid Action in the Prostate.
Zhu, Y. (2005) · PubMed · doi:10.1901/jaba.2005.1-27 · Cited by 45
Yuan, Z. Q., Gottlieb, B., Beitel, L. K., Wong, N., Gordon, P. H., Wang, Q., Puisieux, A., Foulkes, W. D., & Trifiro, M. A. (2002) · Human Mutation · doi:10.1002/humu.10040 · Cited by 45
Wang, F., Liu, X., He, L. N., Liang, K.-N., Miner, J. N., Hong, M., Kallel, E. A., van Oeveren, A., Zhi, L., & Jiang, T. (2006) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309106039340 · Cited by 44
Buchanan, G., Craft, P., Yang, M., Cheong, A., Prescott, J., Li, J., Coetzee, G. A., & Tilley, W. D. (2004) · The Prostate · doi:10.1002/pros.20079 · Cited by 44
Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
Narayanan, R. (2020) · Asian journal of urology · doi:10.1016/j.ajur.2020.03.002 · Cited by 44
Sakkiah, S., Kusko, R. L., Pan, B., Guo, W., Ge, W., Tong, W., & Hong, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00492 · Cited by 44
Stabilization of androgen receptor protein is induced by agonist, not by antagonists
Furutani, T., Watanabe, T., Tanimoto, K., Hashimoto, T., Koutoku, H., Kudoh, M., Shimizu, Y., Kato, S., & Shikama, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00564-8 · Cited by 43
Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression
Brand, L. J., & Dehm, S. M. (2013) · Current Drug Targets · doi:10.2174/1389450111314040005 · Cited by 44
Androgen insensitivity syndrome
Tadokoro‐Cuccaro, R., & Hughes, I. A. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000107 · Cited by 43
Bramble, M. S., Lipson, A., Vashist, N., & Vilain, E. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23832 · Cited by 42
Chen, G., Wang, X., Zhang, S., Lü, Y., Sun, Y., Zhang, J., Li, Z., & Lu, J. (2005) · The Prostate · doi:10.1002/pros.20191 · Cited by 42
Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation
Lavery, D. N., & Bevan, C. L. (2010) · BioMed Research International · doi:10.1155/2011/862125 · Cited by 42
Jin, Y., Duan, M., Wang, X., Kong, X., Zhou, W., Sun, H., Liu, H., Li, D., Yu, H., Li, Y., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00796 · Cited by 42
Fujii, S., Ohta, K., Goto, T., Kagechika, H., & Endo, Y. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.060 · Cited by 42
Yu, S. J., Keenan, S. M., Tong, W., & Welsh, W. J. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0255875 · Cited by 42
9-cis-Retinoic Acid Inhibits Androgen Receptor Activity through Activation of Retinoid X Receptor
Chuang, K., Lee, Y.-F., Lin, W., Chu, C., Altuwaijri, S., Wan, Y. Y., & Chang, C. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0181 · Cited by 41
Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoids
Snaterse, G., Mies, R., van Weerden, W. M., French, P. J., Jonker, J. W., Houtsmuller, A. B., van Royen, M. E., Visser, J. A., & Hofland, J. (2022) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-022-00491-z · Cited by 41
Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids
Issar, M., Sahasranaman, S., Buchwald, P., & Hochhaus, G. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00060005 · Cited by 41
Abdelbaqi, K., Lack, N. A., Guns, E. T., Kotha, L., Safe, S. H., & Sanderson, J. T. (2011) · The Prostate · doi:10.1002/pros.21356 · Cited by 41
Diagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., & Josso, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00119-0 · Cited by 40
Mechanisms of prostate cancer progression to androgen independence
McPhaul, M. J. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.02.006 · Cited by 40
Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer
Hou, Z., Huang, S., Mei, Z., Chen, L., Guo, J., Gao, Y., Zhuang, Q., Zhang, X., Tan, Q., Yang, T., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100561 · Cited by 40
Lusher, S. J., Raaijmakers, H. C. A., Vu‐Pham, D., Kazemier, B., Bosch, R., McGuire, R., Azevedo, R., Hamersma, H., Dechering, K. J., Oubrie, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308403 · Cited by 40
Identification of Novel Androgen Receptor Antagonists Using Structure- and Ligand-Based Methods
Li, H., Ren, X., Leblanc, E., Frewin, K., Rennie, P. S., & Cherkasov, A. R. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300514v · Cited by 40
Selvaraj, D., Muthu, S., Kotha, S., Siddamsetty, R. S., Andavar, S., & Saravanan, J. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1715261 · Cited by 39
A new highly androgen specific yeast biosensor, enabling optimisation of (Q)SAR model approaches
Bovee, T. F. H., Lommerse, J. P. M., Peijnenburg, A., Fernandes, E. C. A., & Nielen, M. W. F. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.035 · Cited by 39
Chapter 17. Selective androgen receptor modulators (SARMs)
Zhi, L., & Martinborough, E. (2001) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(01)36057-8 · Cited by 38
Sakkiah, S., Wang, T., Zou, W., Wang, Y., Pan, B., Tong, W., & Hong, H. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010025 · Cited by 38
Developmental aspects of androgen action
Hughes, I. A., Lim, H. N., Martin, H., Mongan, N. P., Dovey, L., Ahmed, S. F., & Hawkins, J. R. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00622-0 · Cited by 38
QSAR models in receptor-mediated effects: the nuclear receptor superfamily
Fang, H., Tong, W., Welsh, W. J., & Sheehan, D. M. (2003) · Journal of Molecular Structure THEOCHEM · doi:10.1016/s0166-1280(02)00623-1 · Cited by 38
Structure of the Glucocorticoid Receptor, a Flexible Protein That Can Adapt to Different Ligands
Veleiro, A. S., Álvarez, L. D., Eduardo, S. L., & Burton, G. (2010) · ChemMedChem · doi:10.1002/cmdc.201000014 · Cited by 37
Awais, M., Sato, M., Lee, X., & Umezawa, Y. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503185 · Cited by 37
Sakkiah, S., Ng, H. W., Tong, W., & Hong, H. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1192131 · Cited by 36
Sex, infertility and the molecular biology of the androgen receptor
Loy, C. J., & Yong, E. (2001) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200106000-00012 · Cited by 36
Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor
Xiao, L., Cui, X., Madison, V., White, R. E., & Cheng, K.-C. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.9.951 · Cited by 36
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer
Asangani, I. A., Blair, I. A., Duyne, G. D. V., Hilser, V. J., Moiseenkova‐Bell, V. Y., Plymate, S. R., Sprenger, C. C. T., Wand, A. J., & Penning, T. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.012411 · Cited by 35
A new generation of progesterone receptor modulators
Winneker, R. C., Fensome, A., Zhang, P., Yudt, M. R., McComas, C. C., & Unwalla, R. J. (2008) · Steroids · doi:10.1016/j.steroids.2008.03.005 · Cited by 35
Design and Synthesis of an Array of Selective Androgen Receptor Modulators
Trump, R. P., Blanc, J.-B. E., Stewart, E. L., Brown, P. J., Caivano, M., Gray, D. W., Hoekstra, W. J., Willson, T. M., Han, B., & Turnbull, P. (2006) · Journal of Combinatorial Chemistry · doi:10.1021/cc060096e · Cited by 35
Ong, Y. C., Kolatkar, P. R., & Yong, E. L. (2002) · Molecular Human Reproduction · doi:10.1093/molehr/8.2.101 · Cited by 35
Phytoestrogens as Potential Antiandrogenic Agents Against Prostate Cancer: An In Silico Analysis
Agrawal, N., Mujwar, S., Goyal, A., & Gupta, J. K. (2021) · Letters in Drug Design & Discovery · doi:10.2174/1570180818666210813121431 · Cited by 35
Jasuja, R., Catlin, D. H., Miller, A., Chang, Y., Herbst, K. L., Starcevic, B., Artaza, J. N., Singh, R., Datta, G. D., Sarkissian, A., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0448 · Cited by 34
Total synthesis, chemical modification and structure-activity relationship of bufadienolides
Zhong, Y., Zhao, C., Wu, W., Fan, T.-Y., Li, N., Chen, M., Duan, J., & Shi, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112038 · Cited by 34
Docking and CoMSIA studies on steroids and non-steroidal chemicals as androgen receptor ligands
Wang, X., Li, X., Shi, W. F., Wei, S., Giesy, J. P., Yu, H., & Wang, Y. (2012) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2012.11.020 · Cited by 34
Androgen receptor and caveolin‐1 in prostate cancer
Bennett, N. J., Hooper, J. D., Lee, C. S., & Gobe, G. C. (2009) · IUBMB Life · doi:10.1002/iub.244 · Cited by 33
The role of androgen receptors in atherosclerosis
Takov, K., Wu, J., Denvir, M. A., Smith, L. B., & Hadoke, P. W. F. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.006 · Cited by 33
Xie, Y., Tian, Y., Zhang, Y., Zhang, Z., Chen, R., Li, M., Tang, J., Bian, J., Li, Z., & Xu, X. J. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114119 · Cited by 33
Rajender, S., Shastry, P. K., Rasalkar, A. A., Singh, L., & Thangaraj, K. (2006) · Journal of Andrology · doi:10.2164/jandrol.05181 · Cited by 33
Egner, U., Heinrich, N., Ruff, M., Gangloff, M., Mueller‐Fahrnow, A., & Wurtz, J. (2001) · Medicinal Research Reviews · doi:10.1002/med.1024 · Cited by 32
Self-citationImpact of the Protein Data Bank on antineoplastic approvals
Westbrook, J., Soskind, R., Hudson, B. P., & Burley, S. K. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.02.002 · Cited by 32
Brown, T. R. (2004) · Endocrinology · doi:10.1210/en.2004-1207 · Cited by 31
Implication of androgen receptor in urinary bladder cancer: a critical mini review.
Rahmani, A. H., Alzohairy, M. A., Babiker, A. Y., Khan, A. A., Aly, S. M., & Rizvi, M. M. A. (2013) · Europe PMC (PubMed Central) · Cited by 31
Marwah, P., Marwah, A. K., Lardy, H. A., Miyamoto, H., & Chang, C. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.05.022 · Cited by 31
Mongan, N. P., Jääskeläinen, J., Green, K., Schwabe, J. W. R., Shimura, N., Dattani, M., & Hughes, I. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8329 · Cited by 31
Wakabayashi, K.-I., Imai, K., Miyachi, H., Hashimoto, Y., & Tanatani, A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.063 · Cited by 31
New Opportunities for Targeting the Androgen Receptor in Prostate Cancer
Centenera, M. M., Selth, L. A., Ebrahimie, E., Butler, L. M., & Tilley, W. D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030478 · Cited by 30
Cogan, P. S., & Koch, T. H. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0303305 · Cited by 30
Evolution of the androgen receptor: Perspectives from human health to dancing birds
Schuppe, E. R., Miles, M. C., & Fuxjager, M. J. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110577 · Cited by 29
Yu, T., Nantasenamat, C., Kachenton, S., Anuwongcharoen, N., & Piacham, T. (2023) · ACS Omega · doi:10.1021/acsomega.2c07346 · Cited by 29
Bisphenol A (BPA) binding on full‐length architectures of estrogen receptor
Liu, Y., Qu, K., Hai, Y., & Zhao, C. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26872 · Cited by 29
From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
Pennuto, M., & Rinaldi, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.005 · Cited by 29
Tahiri, B., Auzou, G., Nicolas, J., Sultan, C., & Lupo, B. (2001) · Biochemistry · doi:10.1021/bi010146q · Cited by 29
Biron, É., & Bédard, F. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.006 · Cited by 28
Bisson, W. H., Abagyan, R. A., & Cavasotto, C. N. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2008.08.001 · Cited by 28
Takeda, A., Pinon, G. M., Bens, M., Fagart, J., Rafestin-Oblin, M. E., & Vandewalle, A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.031112 · Cited by 28
Chen, J., Hwang, D., Chung, K., Bohl, C. E., Fisher, S. J., Miller, D. D., & Dalton, J. T. (2005) · Endocrinology · doi:10.1210/en.2005-0732 · Cited by 27
Chukhu, M., Dahiya, U. R., & Heemers, H. V. (2025) · Oncogene · doi:10.1038/s41388-025-03573-z · Cited by 27
Féau, C., Arnold, L. A., Kosinski, A. M., & Guy, R. K. (2009) · SLAS DISCOVERY · doi:10.1177/1087057108326662 · Cited by 27
Yang, S., Song, C.-H., Van, H. T. M., Park, E., Khadka, D. B., Gong, E., Lee, K., & Cho, W. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3014103 · Cited by 27
Tachibana, K., Imaoka, I., Shiraishi, T., Yoshino, H., Nakamura, M., Ohta, M., Kawata, H., Taniguchi, K., Ishikura, N., Tsunenari, T., et al. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1555 · Cited by 27
The helix 1–3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones
Cluning, C., Ward, B. K., Rea, S. L., Arulpragasam, A., Fuller, P. J., & Ratajczak, T. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1023 · Cited by 26
Molecular mechanisms of prostate cancer
Trapman, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)80013-7 · Cited by 26
Faucher, F., Cantin, L., de Jesus-Tran, K. P., Lemieux, M., Luu-The, V., Labrie, F., & Breton, R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.058 · Cited by 26
A New Strategy for Selective Targeting of Progesterone Receptor With Passive Antagonists
Khan, J. A., Tikad, A., Fay, M., Hamzé, A., Fagart, J., Chabbert‐Buffet, N., Méduri, G., Amazit, L., Brion, J., Alami, M., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1328 · Cited by 26
Phenotypic and molecular characteristics of androgen insensitivity syndrome patients
Tan, Y., Yuan, S., Zhang, Y., Du, J., Li, W., Tu, C., Meng, L., Lin, G., & Lu, G. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_17_18 · Cited by 26
The emergence of resistance to targeted cancer therapeutics
Mellinghoff, I. K., & Sawyers, C. L. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.5.603 · Cited by 26
Chen, Y., & Lan, T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1451957 · Cited by 25
Androgen Receptor Modulators: A Marriage of Chemistry and Biology
McEwan, I. J. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.69 · Cited by 25
Feldkoren, B., & Andersson, S. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.036 · Cited by 25
Hoppe, C., Steinbeck, C., & Wohlfahrt, G. (2005) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2005.09.013 · Cited by 25
Metadata
- Authors
- Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., Bäsler, S., Schäfer, M., Egner, U., & Carrondo, M. A.
- Affiliations
- Universidade Nova de Lisboa (PT)
- Instituto de Biologia Experimental e Tecnológica (PT)
- Corresponding author
- Carrondo, Maria Arménia
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 34
- Pages
- 26164-26171
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2151922331
- Cited by
- 608
- References
- 53
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 14 · 2023: 20 · 2022: 17 · 2021: 12 · 2020: 18 · 2019: 11 · 2018: 13 · 2017: 14 · 2016: 16 · 2015: 23 · 2014: 12 · 2013: 22 · 2012: 17
- FWCI
- 37.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7373 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- androgen receptor, ligand-binding domain, ligand specificity, progesterone receptor, binding pocket, point mutations, prostate cancer, crystal structure
- MeSH terms
- Amino Acid Sequence, Binding Sites, Humans, Ligands, Male, Models, Chemical, Models, Molecular, Molecular Conformation, Molecular Sequence Data, Prostatic Neoplasms, Protein Conformation, Receptors, Androgen, Metribolone, Mutagenesis, Site-Directed, Crystallography, X-Ray, Amino Acid Substitution, Testosterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.